Corient Private Wealth LLC grew its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 0.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 93,568 shares of the financial services provider’s stock after acquiring an additional 845 shares during the period. Corient Private Wealth LLC’s holdings in CME Group were worth $21,731,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in CME. Geode Capital Management LLC lifted its position in shares of CME Group by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock worth $1,823,964,000 after buying an additional 142,692 shares during the period. Raymond James Financial Inc. bought a new position in shares of CME Group during the fourth quarter valued at $871,063,000. Janus Henderson Group PLC boosted its stake in shares of CME Group by 17.8% in the 3rd quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock valued at $554,707,000 after purchasing an additional 380,071 shares in the last quarter. Capital Wealth Planning LLC grew its holdings in shares of CME Group by 69.2% in the 4th quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider’s stock worth $565,671,000 after purchasing an additional 996,498 shares during the last quarter. Finally, Franklin Resources Inc. increased its position in shares of CME Group by 70.4% during the 3rd quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock worth $544,157,000 after purchasing an additional 1,003,119 shares in the last quarter. 87.75% of the stock is owned by institutional investors.
CME Group Stock Performance
CME Group stock opened at $266.49 on Wednesday. The company has a market cap of $96.03 billion, a PE ratio of 27.56, a PEG ratio of 6.76 and a beta of 0.53. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $266.63. The company’s 50-day moving average is $244.35 and its two-hundred day moving average is $233.28.
CME Group declared that its board has authorized a stock buyback plan on Thursday, December 5th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to reacquire up to 3.4% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.
CME Group Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be given a $1.25 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a dividend yield of 1.88%. The ex-dividend date is Friday, March 7th. CME Group’s dividend payout ratio (DPR) is currently 51.71%.
Insider Buying and Selling
In related news, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the transaction, the chief operating officer now owns 8,036 shares in the company, valued at approximately $2,063,885.88. The trade was a 15.73 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Howard J. Siegel sold 10,000 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the completion of the sale, the director now owns 21,873 shares in the company, valued at approximately $5,686,980. This trade represents a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 27,076 shares of company stock valued at $6,871,496 over the last three months. Company insiders own 0.30% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have commented on the stock. Citigroup lowered shares of CME Group from a “buy” rating to a “neutral” rating and reduced their price target for the company from $255.00 to $250.00 in a research report on Monday, January 6th. JPMorgan Chase & Co. boosted their target price on CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Raymond James raised CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target for the company in a report on Monday, March 10th. Piper Sandler boosted their price objective on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Finally, Keefe, Bruyette & Woods raised their target price on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research note on Friday, February 14th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $238.93.
Get Our Latest Analysis on CME Group
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- What is the Nikkei 225 index?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How to Start Investing in Real Estate
- 3 Must-Own Stocks to Build Wealth This Decade
- How to buy stock: A step-by-step guide for beginners
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.